Theglobal 'Conjunctivitistreatment market size' is set to gain traction from the rising technologicaladvancements in the field of ophthalmology. Besides, the increasing discoveryof new techniques of drug delivery would also impact the market positively.This information is given by Fortune Business Insights™ in a recently publishedreport, titled, “Conjunctivitis Treatment Market Size, Share & COVID-19Impact Analysis, By Drug Class (Antibiotics, Antiviral, Anti-allergic,Artificial Tear and Others), By Disease Type (Bacterial Conjunctivitis, ViralConjunctivitis, and Allergic Conjunctivitis) By Route of Administration(Topical, Oral, and Intravitreal), By Distribution Channel (HospitalPharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores), andRegional Forecast, 2020-2027.” The report further states that theconjunctivitis treatment market size was USD 3.85 billion in 2019 and isprojected to reach USD 4.38 billion by 2027, exhibiting a CAGR of 3.7% duringthe forecast period.
Have Any Query? Ask Our Experts:
Regional Analysis-
North America to Dominate Fueled by Presence of Several IndustryGiants
Geographically,North America procured USD 1.85 billion in terms of revenue in 2019 and isexpected to lead in the near future. This growth is attributable to the risingawareness about eye diseases amongst the masses, presence of industry giants inthe region, and the increasing cases of conjunctivitis. Europe is anticipatedto remain in the second position on account of the surging usage of novel drugsfor conjunctivitis treatment, rising pool of conjunctivitis patients, andincreasing healthcare expenditure in this region.
Frequently Ask Question :
1) How much is the conjunctivitistreatment market worth?
Fortune Business Insights says that the global conjunctivitistreatment market size was USD3.85 billion in 2019 and is projected to reach USD 4.38 billion by 2027.
2) What was the value of the global market in 2019?
In 2019, the market valuestood at USD 3.85 billion.
3) At what CAGR is the global market projected togrow in the forecast Period (2020-2027)?
Registeringa CAGR of 3.7%, the market will exhibit steady growth in the forecast period(2020-2027).
An Overview of the Impact of COVID-19 on this Market :
Theemergence of COVID-19 has brought the world to a standstill. We understand thatthis health crisis has brought an unprecedented impact on businesses acrossindustries. However, this too shall pass. Rising support from governments andseveral companies can help in the fight against this highly contagious disease.There are some industries that are struggling and some are thriving. Overall,almost every sector is anticipated to be impacted by the pandemic.
Weare taking continuous efforts to help your business sustain and grow duringCOVID-19 pandemics. Based on our experience and expertise, we will offer you animpact analysis of corona virus outbreak across industries to help you preparefor the future.
This Report Answers the Following Questions:
- What are the market growth drivers, dynamics, and hindrances?
- Which segment is set to lead the market in the near future?
- Which company would generate the largest revenue?
- How will the companies surge sales of new drugs for conjunctivitis treatment?
Drivers & Restraints-
Rising Awareness Programs about Eye-related Diseases will PropelGrowth
Conjunctivitiscan be of three types, namely, allergic, viral, and bacterial. The NationalCentre for Biotechnology Information mentioned that these types of diseasesvary from person to person according to the season of the year and thepatient’s age. It also spreads rapidly through direct contact, such assneezing, coughing, and hands. Also, numerous companies are trying to launch newdrug formulations and innovative drug delivery systems for faster recovery ofthe patients. Apart from that, ocular disorder management and the increasingawareness programs about eye-related diseases would contribute to theconjunctivitis treatment market growth in the coming years.
COVID-19 to Contribute to a Lower Growth Due to Strong Decline inHospital Visits
Theoutbreak of the COVID-19 pandemic across the globe is set to negatively impactthe global market growth. Despite the patients suffering from conjunctivitistend to be at a high risk of getting injected by viral conjunctiva that isusually caused because of adenovirus, the market is expected to undergo adecline. While coronavirus also causes several similar ocular signs andsymptoms, such as conjunctivitis infection, watery discharge, photophobia, andeye irritation. Due to the stringent lockdowns imposed by governments acrossthe globe, the postponement or cancellations of non-life-threatening medicalvisits is expected to restrict the market growth as lesser prescriptions forconjunctivitis will be issued in this time period.
For more information visit :
https://www.fortunebusinessinsights.com/conjunctivitis-treatment-market-103488
Global Conjunctivitis Treatment Market Segmentation :
By Drug Class
- Antibiotics
- Antiviral
- Anti-allergic
- Artificial Tears
- Others
By Disease Type
- Bacterial Conjunctivitis
- Viral Conjunctivitis
- Allergic Conjunctivitis
By Route of Administration
- Topical
- Oral
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies & Drug Stores
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)
Competitive Landscape-
Key Players Focus on Receiving Fast Track Approvals for Their NewDrugs
Thecompanies operating in the market are presently focusing on investing heftyamounts of money to conduct research and develop activities. These are helpingthem to develop new drugs for conjunctivitis treatment. They are also trying toreceive approvals for their novel drugs from the regulatory bodies. Below aretwo of the latest industry developments:
- April 2020: Ocular Therapeutix™, Inc., a biopharmaceutical firm declared the Phase 3 clinical trial results. It was conducted to find out the efficacy and safety of DEXTENZA® for the treatment of ocular itching caused by allergic conjunctivitis. As per the results, DEXTENZA is capable of treating the disease.
- May 2017: The U.S. Food and Drug Administration (FDA) announced its approval of a New Drug Application (NDA) named Zerviate. It will be used to treat ocular itching that is caused by allergic conjunctivitis. It is considered to be the first topical ocular formulation of Nicox, an ophthalmology company based in France.
Fortune Business Insights™ listsout the names of all the manufacturers of drugs used for conjunctivitistreatment. They are as follows:
- Allergan
- Akorn, Incorporated
- Eyevance Pharmaceuticals LLC.
- NOVARTIS AG
- Santen Pharmaceutical Co., Ltd
- Alcon
- Bausch & Lomb Incorporated
- Others key market players
Request a Sample Copy of the Research Report:
Table Of Content :
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
- Pipeline Analysis
- New Product Launches, Key Market Players
- Prevalence of Conjunctivitis, by key Countries/region
- COVID-19 Impact on Global Conjunctivitis Treatment Market
- Global Conjunctivitis Treatment Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Antibiotics
- Antiviral
- Anti-allergic
- Artificial Tears
- Others
- Market Analysis, Insights and Forecast – By Disease Type
- Bacterial Conjunctivitis
- Viral Conjunctivitis
- Allergic Conjunctivitis
- Market Analysis, Insights and Forecast – By Route of Administration
- Topical
- Oral
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies & Drug Stores
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Continue…
Related Reports:
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accuratedata, helping organizations of all sizes make timely decisions. We tailorinnovative solutions for our clients, assisting them to address challengesdistinct to their businesses. Our goal is to empower our clients with holisticmarket intelligence, giving a granular overview of the market they areoperating in.
Our reports contain a unique mix of tangible insights and qualitative analysisto help companies achieve sustainable growth. Our team of experienced analystsand consultants use industry-leading research tools and techniques to compile comprehensivemarket studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrativegrowth opportunities for our clients. We, therefore, offer recommendations,making it easier for them to navigate through technological and market-relatedchanges. Our consulting services are designed to help organizations identifyhidden opportunities and understand prevailing competitive challenges
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
